ACT Capital Management »

Eiger Biopharmaceuticals shares owned by ACT Capital Management

Quarter-by-quarter ownership of Eiger Biopharmaceuticals shares owned by ACT Capital Management from 13F filings

Historical chart of ACT Capital Management investment in Eiger Biopharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eiger Biopharmaceuticals held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eiger Biopharmaceuticals by ACT Capital Management

Quarter filed Position value Share count Share price at filing
2022-09-30 $1.8M 235k 7.53
2022-06-30 $1.6M 250k 6.30
2022-03-31 $2.1M 250k 8.30
2021-12-31 $823k 159k 5.19
2021-09-30 $1.1M 159k 6.68
2021-06-30 $1.4M 159k 8.52

Top funds holding Eiger Biopharmaceuticals